BeOne Medicines (ONC) SVP Lee Chan Henry Sells Shares

What Happened

• Lee Chan Henry, SVP and General Counsel of BeOne Medicines (ONC), sold 1,044 shares on 2026-07-30 at $323.69 per share, generating $337,932. The transaction is reported as a sale (S) and was effected to satisfy mandatory tax withholding tied to the vesting of restricted share units (RSUs).

Key Details

• Transaction date and price: 2026-07-30 — 1,044 shares at $323.69 each.
• Transaction value: $337,932 (gross proceeds).
• Sale type: Reported as open market or private sale (S); described in the filing as a tax-withholding sale under the RSU award agreement.
• Footnote F1: Each American Depositary Share (ADS) represents 13 ordinary shares.
• Footnote F2: The sale was made to satisfy mandatory tax withholding on RSUs. The award vests 1/4th on each anniversary of July 29, 2022, subject to service; unvested securities may accelerate on certain termination events.
• Shares owned after transaction: Not specified in the Form 4 provided.
• Filing timeliness: Form 4 filed 2026-08-03 for a 2026-07-30 transaction — marked late (transactionTimeliness = 'L').

Context

• This was a tax-withholding sale related to RSU vesting (a common administrative sale), which is generally considered routine and not necessarily an indicator of the insider’s view on the company’s prospects.